Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib plus nivolumab plus /- ipilimumab

被引：0
|
作者：
Iannantuono, Giovanni Maria
Chandran, Elias
Simon, Nicholas I.
Ley, Lisa
Cordes, Lisa M.
Wang, Tzu-fang
Girardi, Daniel da Motta
Gurram, Sandeep
Valera, Vladimir
Chalfin, Heather
Parnes, Howard L.
Nadal, Rosa
Niglio, Scot Anthony
Boudjadi, Salah
Banday, Abdul Rouf
Kydd, Andre Rashad
Steinberg, Seth M.
Apolo, Andrea B.
机构：
[1] NCI, Genitourinary Malignancies Branch, CCR, NIH, Bethesda, MD USA
[2] Hosp Sirio Libanes, Brasilia, MD, Brazil
[3] NCI, Urol Oncol Branch, CCR, NIH, Bethesda, MD USA
[4] Frederick Hlth Hosp, Frederick, MD USA
[5] NCI, Div Canc Prevent, CCR, NIH, Bethesda, MD USA
[6] NHLBI, Cellular & Mol Therapeut Branch, Lab Transplantat Immunotherapy, NIH, Bethesda, MD USA
[7] NYU, Grossman Sch Med, New York, NY USA
[8] NCI, Biostat & Data Management Sect, OCD, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16506
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COMBINED NIVOLUMAB PLUS IPILIMUMAB THERAPY CAUSE HIGHER GRADE AND EARLIER IMMUNE-RELATED ADVERSE EVENTS HEPATITIS OCCURRENCE THAN SINGLE AGENT THERAPY
    Nagashima, Hiroyuki
    Sagawa, Tamotsu
    Hirakawa, Masahiro
    Waga, Eriko
    Fujikawa, Koshi
    Takahashi, Yasuo
    GASTROENTEROLOGY, 2020, 158 (06) : S1307 - S1307
  • [22] The association of FDG PET/CT and NaF PET/CT with survival outcomes in patients (pts) with metastatic genitourinary malignancies (mGU) treated with cabozantinib plus nivolumab plus /- ipilimumab (CaboNivo plus /- Ipi).
    Simon, Nicholas I.
    Lei, Katherine
    Verdini, Nicholas Peter
    Lin, Jeffrey
    Vega, Andy
    Niglio, Scot Anthony
    Mortazavi, Amir
    Pal, Sumanta K.
    Kempf, Jeffrey
    Becker, Murray
    Knopp, Michael V.
    Wright, Chadwick
    Jung, Alex
    Choyke, Peter L.
    Steinberg, Seth M.
    Mena, Esther
    Lindenberg, Liza
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [23] Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
    Washino, Satoshi
    Shirotake, Suguru
    Takeshita, Hideki
    Inoue, Masaharu
    Miura, Yuji
    Hyodo, Yoji
    Kagawa, Makoto
    Izumi, Keita
    Oyama, Masafumi
    Kawakami, Satoru
    Saito, Kazutaka
    Matsuoka, Yoh
    Taniuchi, Satsuki
    Shintani, Ayumi
    Miyagawa, Tomoaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (12) : 1651 - 1658
  • [24] Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
    Satoshi Washino
    Suguru Shirotake
    Hideki Takeshita
    Masaharu Inoue
    Yuji Miura
    Yoji Hyodo
    Makoto Kagawa
    Keita Izumi
    Masafumi Oyama
    Satoru Kawakami
    Kazutaka Saito
    Yoh Matsuoka
    Satsuki Taniuchi
    Ayumi Shintani
    Tomoaki Miyagawa
    International Journal of Clinical Oncology, 2023, 28 : 1651 - 1658
  • [25] Correlation between immune-related adverse events and outcomes in nivolumab/ipilimumab combination therapy for metastatic melanoma
    Rauwerdink, Daan
    Frederick, Dennie T.
    Sharova, Tatyana
    Marie, Genevieve
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [26] ASSOCIATION OF IMMUNE-RELATED ADVERSE EVENTS WITH PROGNOSIS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Homma, Chie
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kobayashi, Hirohito
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2019, 201 (04): : E71 - E71
  • [27] Immune-related adverse events and survival in elderly patients with melanoma treated with ipilimumab
    Mian, Idrees
    Yang, Ming
    Zhao, Hui
    Shah, Mohsin
    Diab, Adi
    Shannon, Vickie
    Patel, Anisha
    Amaria, Rodabe Navroze
    Giordano, Sharon Hermes
    Suarez-Almazor, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Masuda, Ken
    Shoji, Hirokazu
    Nagashima, Kengo
    Yamamoto, Shun
    Ishikawa, Masashi
    Imazeki, Hiroshi
    Aoki, Masahiko
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Boku, Narikazu
    BMC CANCER, 2019, 19 (01)
  • [29] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
    Ken Masuda
    Hirokazu Shoji
    Kengo Nagashima
    Shun Yamamoto
    Masashi Ishikawa
    Hiroshi Imazeki
    Masahiko Aoki
    Takahiro Miyamoto
    Hidekazu Hirano
    Yoshitaka Honma
    Satoru Iwasa
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Narikazu Boku
    BMC Cancer, 19
  • [30] Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Suzuki, Keito
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Matsumoto, Hiroaki
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada-Shimizu, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (06) : 1183 - 1189
12345